Higher risk of bleeding in atrial fibrillation patients taking blood thinner dabigatran

4 noviembre 2014

Patients with atrial fibrillation who take the blood thinner dabigatran are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new study. The findings, based on Medicare claims data, indicate greater caution is needed when prescribing dabigatran to certain high-risk patients.